Answers are grounded in this paper and cite their sources.
Deep learning techniques have greatly improved the ability to perform automatic diagnosis of breast cancer through use of computers; however, existing techniques are generally complex and costly, do not well incorporate multiple data modalities, and cannot be deployed clinically in real time. This paper proposes SQCDL-WIoT, which is a scalable, wearable-based internet of things (IoT)-enabled quantum convolutional deep learning (C-DL) framework capable of multi-class breast cancer screening. The proposed method includes two VQCs with five qubits each that can be embedded into a ResNet-50 back bone. In addition to being able to process images from histopathology and wearable-based bio sensor signals as input, the method also enables the incorporation of both wearable based bio sensor signal processing (i.e., wearable-IoT) and clinical variables via the Squeeze-and-Excitation (SE) attention mechanism. Thus, this proposed method is capable of hybrid quantum-classical training. Using stratified k-folds cross-validation (where k = 5) on the BreaKHis dataset and zero-shot transfer learning on the CBIS-DDSM dataset, SQCDL-WIoT demonstrated the highest accuracy (98.14%) with the highest sensitivity (macro-sensitivity = 97.63%), specificity (macro-specificity = 98.87%), and area under curve (AUC = 0.9891) when compared to all other baseline methods at 40x magnification on BreaKHis. Additionally, SQCDL-WIoT demonstrated 93.41% accuracy on the CBIS-DDSM dataset via zero shot learning, indicating good cross-domain generalization. Finally, the wearable IoT sub-system demonstrated a mean real-time edge-inference latency of 378 ± 12 milliseconds on an ARM Cortex-A72 processor, meeting the defined clinical threshold for response of < 400 milliseconds. The results of ablation studies indicated that both quantum convolution and SE attention contributed to complementary and synergetic increases in performance compared to classical ResNet-50 baseline models. Overall, the collective results presented here indicate that the proposed hybrid quantum-classical DL framework combined with wearable-based IoT sensing may represent a viable solution to scalable and intelligent breast cancer screening.
No takes yet. Share an insight, caveat, or question.
Ramudu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: